Testing targeted microwave ablation for early prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This study tests a new, less invasive treatment using targeted microwave ablation (TMA) to destroy prostate cancer tumors. It is designed for men with early-stage, low to intermediate-risk prostate cancer that hasn't spread, offering a possible alternative to surgery or radiation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between 45 and 75 years old.
- Your overall health is good enough that you are expected to live at least 10 more years.
- You have a low or intermediate-risk prostate cancer that shows up on MRI and was confirmed by biopsy.
- The tumor is 15mm or smaller, and you have no more than 2 visible spots of cancer on MRI.
- You have not had any prior treatment for prostate cancer or pelvic radiation.
- You are able to have an MRI with contrast (your kidneys work well enough) and are okay with anesthesia.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a precisely targeted laser procedure—guided by MRI images—can treat prostate cancer. It may help some men who have a certain type and location of tumor while aiming to avoid nearby sensitive structures.
This trial tests a laser treatment that targets only the cancerous part of the prostate. It may be an option for men with intermediate-risk prostate cancer who do not want their entire prostate removed.
This trial tests a targeted treatment for prostate cancer using PSMA imaging to guide ablation (removal) of the tumor. It may help men with early-stage, localized cancer that hasn't spread.
This trial tests if giving fewer radiation treatments using a special MRI-guided machine is safe and effective for men with prostate cancer. It may help reduce side effects while still controlling the cancer.
This trial tests a minimally invasive prostate treatment using MRI guidance and a focal laser to destroy only the cancer spot (not the whole prostate). If you have low-to-intermediate risk, MRI-visible prostate cancer in a limited area, it may help control the cancer while potentially reducing treatment side effects.
This study uses a special kind of MRI to better “map” prostate cancer inside the prostate. Researchers compare the MRI results with the detailed tissue exam after prostate surgery to see how accurate the imaging is.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.